Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prebiotic dietary fiber refers to dietary fiber compounds that are resistant to human digestion but selectively fermented by beneficial gut microbiota, resulting in improved host health outcomes. Prebiotics include specific carbohydrate types (such as inulin, fructooligosaccharides, galactooligosaccharides, and resistant starch) and, in some cases, non-carbohydrate compounds (e.g., certain polyphenols). They are found naturally in foods like onions, garlic, asparagus, oats, legumes, and some fruits. Not all fibers are prebiotics; to be classified as prebiotic, a fiber must (1) resist digestion in the upper GI tract, (2) serve as a substrate for beneficial colonic bacteria, and (3) confer a health benefit via microbial fermentation. Prebiotics are not molecular drug targets or receptors, but nutritional ingredients aimed at modulating the gut ecosystem for health purposes. Clarifications/Issues: "Prebiotic dietary fiber" is not a discrete target, molecule, receptor, or drug-interacting protein. It is a class of food components with effects mediated via the gut microbiome rather than through traditional molecular pharmacology. Its inclusion as a “target” is incorrect; interactions and effects are largely indirect and population-level. Definitions and health claims about prebiotic fibers are debated and regulated variably worldwide, especially in distinguishing "fiber" from "prebiotic" for labeling and health claims. Summary: "Prebiotic dietary fiber" does not meet the criteria for a canonical molecular target, enzyme, receptor, or similar entity as used in drug discovery or molecular biology. It is best considered a functional food group that acts through modulation of the microbiome and related metabolic effects.
Selective fermentation by gut bacteria. Stimulation of beneficial bacterial growth (e.g., Bifidobacteria, Lactobacilli). Production of short-chain fatty acids (butyrate, propionate, acetate). Modulation of host immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prebiotic dietary fiber.